Report Overview

Diabetes is a chronic disease that occurs either when the pancreas fails to produce adequate insulin or when the body fails to use the insulin that it generates. Insulin is a hormone that helps to keep blood sugar levels in check.

Global Diabetes Care Devices Market- Industry Trends & Forecast Report 2027

The global diabetes care devices market was worth USD 8.9 billion in 2020 and is further projected to reach USD 14.0 billion by the year 2027, growing at the CAGR of 6.7% in the forecast period (2021-2027). Globally, the diabetes care devices market is progressing due to the increasing prevalence of diabetes around the world and the increasing acceptance of diabetes monitoring and management devices. As a result of raising awareness of this chronic disease, this market is expected to blossom during the forecast period.

                                   

                                                                 Source: BlueWeave Consulting

Global Diabetes Care Devices Market- Overview

Diabetes is a chronic disease that occurs either when the pancreas fails to produce adequate insulin or when the body fails to use the insulin that it generates. Insulin is a hormone that helps to keep blood sugar levels in check. Over time, glucose (blood sugar) accumulates in the bloodstream without insulin, making it easier for it to become concentrated. The rise in blood sugar levels in your blood is caused by the accumulation of glucose in your bloodstream.

According to the World Health Organization, diabetes claimed the lives of 1.5 million people in 2019. There is currently no cure for diabetes; however, it can be controlled by managing one’s blood sugar levels. Diabetes increases a person's risk of developing heart disease, stroke, kidney disease, and eye problems, therefore diabetes care devices are used to reduce such risks. Diabetes care devices are used for monitoring and regulating the glucose level in a diabetic patient’s body. Blood glucose test strips, ketone monitors, insulin pens, syringes, pumps, and injectors are some of the most commonly used diabetes care devices.

Global Diabetes Care Devices Market Forecast and Trends

Growth Drivers

Rising Prevalence of Diabetes all around the world

The prevalence of diabetes in developing countries like China and India is increasing rapidly at an alarming rate. Diabetes was formerly a condition only associated with the geriatric population; however, it is becoming increasingly prevalent among young people as well. A report released by the American Diabetes Association revealed that the prevalence of diabetes among Americans under 20 is estimated to be about 210,000. The report further states that the incidence of type 1 and type 2 diabetes among youth was estimated to be 18,200 and 5,800, respectively, in 2014-15.

Increased urbanization, obesity, sedentary lifestyles, and lack of adequate knowledge about diabetes are some of the causes of the rising prevalence of diabetes. Thus, the market for diabetes care devices market is progressing swiftly and is estimated to gain traction in the forecast period.

Increasing Adoption of Technologically-advanced Diabetes Care Products

The need for diabetes care equipment is increasing as improved diabetes monitoring systems and treatment devices become more widely used. The healthcare facilities are rapidly installing and using diabetes care devices as they facilitate accurate measurements and monitoring. Simultaneously, the market players are also launching a wide range of diabetes care devices that cater to the needs of patients suffering from various types of diabetes. For instance, smart glucose level monitoring and insulin delivery solutions have been witnessing an increased demand as a result of their sophisticated technological features, which include integration with digital health solutions, data collection, as well as more precise and cost-effective management of diabetes. Thus, the wide acceptance of technologically advanced diabetes care devices is likely to drive the global diabetes care devices market in the forecast period.

Restraints

Nonavailability of Sufficient Reimbursement Insurance Policies

High diagnosis and treatment costs act as a significant deterrent to market growth. Developed nations like the USA, UK, Spain, Canada, and so on, have well-structured reimbursement insurance policies in place which boost the overall healthcare sector of such regions. However, in growing economies such as China, India, and South Korea, this concept of healthcare insurance is still relatively new. Potential markets, such as India, have some health insurance and reimbursement policies in place, but it will take some time for them to acquire traction. The adoption of advanced diabetes care devices is restricted as a result of this limitation. Moreover, lack of awareness regarding the benefits of such devices is also hindering the market growth.

Impact of Covid-19 on Global Diabetes Care Devices Market

With the sudden emergence of Covid-19-induced pandemic, the global diabetes care market experienced a mixed response. During the lockdown, the number of people visiting hospitals decreased dramatically, resulting in a decrease in demand for diabetes care devices. On the other hand, the trend of home-care monitoring and management of diabetes rose during the lockdown phase, which further propelled the demand for these devices. Furthermore, the Covid-19 pandemic may make a diabetic more vulnerable to severe illness. Thus, the rising number of Covid-19 cases may lead to a spike in the demand for diabetes care products in the foreseeable future.

Global Diabetes Care Devices Market - By Type

Based on types, the global diabetes care market is segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. Blood glucose monitoring systems recorded the largest market share in the year 2020. The availability of technologically advanced devices and a range of diabetes care products such as smart insulin patches, insulin inhalers, closed-loop systems, etc. is significantly boosting the demand for blood glucose monitoring systems. However, diabetes management mobile applications are estimated to gain traction in the forecast period with a healthy CAGR.

Global Diabetes Care Devices Market - By End-User

Based on end-users, the global diabetes care market is categorized into hospitals, diabetes specialty clinics, and self-home healthcare. The hospital segment held the largest market share in 2020 owing to factors such as increasing hospitalization of patients, especially those belonging to the geriatric population. For monitoring and managing the blood sugar level, the accurate measurement of blood glucose is very crucial to avoid any complications. The demand for diabetes care devices in hospitals is estimated to boost in the forecast period due to the increasing adoption of advanced technology in these healthcare facilities.

Global Diabetes Care Devices Market - Regional Insights

Geographically, the global diabetes care devices market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among these regions, North America accounted for the largest share in the market. The rising number of people suffering from diabetes, along with the presence of major players in the region, are contributing to the growth of diabetes care devices in this region. However, the Asia-Pacific region is also estimated to witness a healthy CAGR in the forecast period owing to the increasing number of diabetes patients in the regions. According to a report released in 2016 by the WHO, China has 110 million people living with diabetes, which is nearly 10% of all adults. The report further states that the number is expected to rise to 150 million by the year 2040, with serious health, social, and economic consequences.

Competitive Landscape

The leading market players in the global diabetes care devices market are Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., Rossmax International Ltd., Medtronic PLC, Sinocare, Inc., Ascensia Diabetes Care Holdings AG, Abbott, Rossmax International Ltd., Arkray, Inc., Dexcom, Inc., Bionime Corporation, Lifescan, Dr. Morepen, Sanofi, B. Braun Melsungen AG, Acon Laboratories, Inc., Becton, Dickinson And Company, Ypsomed, Terumo Corporation, and other prominent players. The companies are consistently focusing on offering a wide range of sophisticated diabetes care devices to maintain and expand their presence in several regions of the world.

Recent Developments

• In May 2021, Bigfoot Biomedical, a US-based medical technology startup, announced to have received FDA clearance for the Bigfoot Unity Diabetes Management System. This smartpen cap for insulin pens has been devised to treat Type1 and Type2 diabetes.

• In April 2021, BIOCORP, a French medical device company announced the launch of ‘Mallya’, a medical device in collaboration with Roche Diabetes Care France. ‘Mallya’ is a smart insulin pen device that can accurately collect and transfer insulin data.

Scope of the Report

Attributes	Details
Years Considered	Historical data – 2017-2020
	Base Year – 2020
	Forecast – 2021 – 2027
Facts Covered	Revenue in USD Million
Market Coverage	North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa
Product Service/Segmentation	By Type, By End-User, By Region
Key Players	Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., Rossmax International Ltd., Medtronic PLC, Sinocare, Inc., Ascensia Diabetes Care Holdings AG, Abbott, Rossmax International Ltd., Arkray, Inc., Dexcom, Inc., Bionime Corporation, Lifescan, Dr. Morepen, Sanofi, B. Braun Melsungen AG, Acon Laboratories, Inc., Becton, Dickinson And Company, Ypsomed, Terumo Corporation, and other prominent players

 

By Type

• Blood Glucose Monitoring Systems

1. Self-Monitoring Blood Glucose Monitoring Systems
2. Test Strips/Test Papers
3. Lancets/Lancing Devices

• Insulin Delivery Devices

1. Insulin Pumps
2. Insulin Pens
3. Insulin Syringes and Needles

• Diabetes Management Mobile Applications

By End-User

• Hospitals
• Diabetes Specialty Clinics
• Self-Home Healthcare

By Region

• North America
• Europe
• Asia-Pacific (APAC)
• Latin America (LATAM)
• Middle-East & Africa (MEA)

1. Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary and Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary and Secondary Sources

2.3. Breakdown of Primary Research Respondents

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Industry Participants

2.5. Key Questionnaire asked during Primary Interviews

2.6. Key Primary Responses

2.7. Market Size Estimation

2.8. Assumption for the Study

2.9. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Diabetes Care Devices Market Market – Industry Insights

4.1. DROC Analysis

4.1.1.   Growth Drivers

4.1.2.   Restraints

4.1.3.   Opportunity

4.1.4.   Challenges

4.2. Recent Developments / Technical Landscape

4.3. Regulatory Framework

4.4. Porter’s Five Forces Analysis

4.5. Value Chain Analysis

4.6. Strategic Outlook

5.    Global Diabetes Care Devices Market Overview

5.1. Market Estimates & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast

5.2.1.  By Type

5.2.1.1. Blood Glucose Monitoring Systems

5.2.1.1.1.      Self-Monitoring Blood Glucose Monitoring Systems

5.2.1.1.2.      Test Strips/Test Papers

5.2.1.1.3.      Lancets/Lancing Devices

5.2.1.2. Insulin Delivery Devices

5.2.1.2.1.      Insulin Pumps

5.2.1.2.2.      Insulin Pens

5.2.1.2.3.      Insulin Syringes And Needles

5.2.1.3. Diabetes Management Mobile Applications

5.2.2.   By End-User

5.2.2.1. Hospitals

5.2.2.2. Diabetes Specialty Clinics

5.2.2.3. Self-Home Healthcare

5.2.3.   By Region

5.2.3.1. North America

5.2.3.2. Europe

5.2.3.3. Asia-Pacific (APAC)

5.2.3.4. Latin America (LATAM)

5.2.3.5. Middle-East & Africa (MEA)

6.    North America Diabetes Care Devices Market Overview

6.1. Market Size and Forecast

6.1.1.   By Value (USD Million), 2017-2027

6.2. Market Share and Forecast

6.2.1.   By Application

6.2.2.   By Regime

6.2.3.   By Country

6.2.3.1. U.S.

6.2.3.2. Canada

7.    Europe Diabetes Care Devices Market Overview

7.1.     Market Size and Forecast

7.1.1.   By Value (USD Million), 2017-2027

7.2.     Market Share and Forecast

7.2.1.   By Application

7.2.2.   By Regime

7.2.3.   By Country

7.2.3.1.   Germany

7.2.3.2.   U.K.

7.2.3.3.   France

7.2.3.4.   Italy

7.2.3.5.   Spain

7.2.3.6.   Russia

7.2.3.7.   Netherlands

7.2.3.8.   Rest of Europe

8.    APAC Diabetes Care Devices Market Overview

8.1.     Market Size and Forecast

8.1.1.   By Value (USD Million), 2017-2027

8.2.     Market Share and Forecast

8.2.1.   By Application

8.2.2.   By Regime

8.2.3.   By Country

8.2.3.1.   China

8.2.3.2.   India

8.2.3.3.   Japan

8.2.3.4.   South Korea

8.2.3.5.   Rest of APAC

9.    LATAM Diabetes Care Devices Market Overview

9.1.     Market Size and Forecast

9.1.1.   By Value (USD Million), 2017-2027

9.2.     Market Share and Forecast

9.2.1.   By Application

9.2.2.   By Regime

9.2.3.   By Country

9.2.3.1.   Mexico

9.2.3.2.   Brazil

9.2.3.3.   Rest of LATAM

10.MEA Diabetes Care Devices Market Overview

10.1.   Market Size and Forecast

10.1.1.                By Value (USD Million), 2017-2027

10.2.   Market Share and Forecast

10.2.1.                By Application

10.2.2.                By Regime

10.2.3.                By Country

10.2.3.1.              Saudi Arabia

10.2.3.2.              UAE

10.2.3.3.              South Africa

10.2.3.4.              Turkey

10.2.3.5.              Rest of Europe

11.Competitive Landscape

11.1.1.                List of Key Players and Their Offerings

11.1.2.                Market Share / Ranking Analysis (2020)

11.1.3.                Competitive Benchmarking, By Operating Parameters

12.COVID-19 Impact

12.1.             Future Impact

12.2.             Key Developments during COVID-19

12.3.             Impact on Market

12.3.1.                Different Scenario

12.3.2.                Impact on Companies

12.4.             Regional Impact

13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

13.1.             Novo Nordisk A/S

13.2.             F. Hoffman-La Roche Ltd.

13.3.             Rossmax International Ltd.

13.4.             Medtronic Plc

13.5.             Sinocare, Inc.

13.6.             Ascensia Diabetes Care Holdings AG

13.7.             Abbott

13.8.             Rossmax International Ltd.

13.9.             Arkray, Inc.

13.10.          Dexcom, Inc.

13.11.          Bionime Corporation

13.12.          Lifescan

13.13.          Dr. Morepen

13.14.          Sanofi

13.15.          B. Braun Melsungen AG

13.16.          Acon Laboratories, Inc.

13.17.          Becton, Dickinson And Company

13.18.          Ypsomed

13.19.          Terumo Corporation

13.20.          Other Prominent Players

14. Key Strategic Recommendations

 

* Financial information of non-listed Companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.

 

List of Figures

 

Fig: Global Diabetes Care Devices Segmentation

 

Fig: Global Diabetes Care Devices Value Chain Analysis,

 

Fig: Company Market Share Analysis, 2020

 

Fig: Global Diabetes Care Devices Size, By Value (USD Million), 2017-2027

 

Fig: Global Diabetes Care Devices Share (%), By Application, By Value, 2017-2027

 

Fig: Global Diabetes Care Devices Share (%), By End User, By Value, 2017-2027

 

Fig: Global Diabetes Care Devices Share (%), By Country, By Value, 2017-2027

 

Fig: North America Diabetes Care Devices Size, By Value (USD Million), 2017-2027

 

Fig: North America Diabetes Care Devices Share (%), By Application, By Value, 2017-2027

 

Fig: North America Diabetes Care Devices Share (%), By End User, By Value, 2017-2027

 

Fig: North America Diabetes Care Devices Share (%), By Country, By Value, 2017-2027

 

Fig: Europe Diabetes Care Devices Size, By Value (USD Million), 2017-2027

 

Fig: Europe Diabetes Care Devices Share (%), By Application, By Value, 2017-2027

 

Fig: Europe Diabetes Care Devices Share (%), By End User, By Value, 2017-2027

 

Fig: Europe Diabetes Care Devices Share (%), By Country, By Value, 2017-2027

 

Fig: the Asia-Pacific Diabetes Care Devices Size, By Value (USD Million), 2017-2027

 

Fig: the Asia-Pacific Diabetes Care Devices Share (%), By Application, By Value, 2017-2027

 

Fig: the Asia-Pacific Diabetes Care Devices Share (%), By End User, By Value, 2017-2027

 

Fig: Asia-Pacific Diabetes Care Devices Share (%), By Country, By Value, 2017-2027

 

Fig: Latin America Diabetes Care Devices Size, By Value (USD Million), 2017-2027

 

Fig: Latin America Diabetes Care Devices Share (%), By Application, By Value, 2017-2027

 

Fig: Latin America Diabetes Care Devices Share (%), By End User, By Value, 2017-2027

 

Fig: Latin America Diabetes Care Devices Share (%), By Country, By Value, 2017-2027

 

Fig: Middle East & Africa Diabetes Care Devices Size, By Value (USD Million), 2017-2027

 

Fig: Middle East & Africa Diabetes Care Devices Share (%), By Application, By Value, 2017-2027

 

Fig: Middle East & Africa Diabetes Care Devices Share (%), By End User, By Value, 2017-2027

 

Fig: Middle East & Africa Diabetes Care Devices Share (%), By Region, By Value, 2017-2027

 

 

 

List of Tables

 

Table: Global Diabetes Care Devices Size, By Application, By Value, 2017-2027

 

Table: Global Diabetes Care Devices Size, By End User, By Value (USD Million), 2017-2027

 

Table: Global Diabetes Care Devices Size, By Region, By Value (USD Million), 2017-2027

 

Table: North America Diabetes Care Devices Size, By Application, By Value (USD Million), 2017-2027

 

Table: North America Diabetes Care Devices Size, By End User, By Value (USD Million), 2017-2027

 

Table: North America Diabetes Care Devices Size, By Country, By Value (USD Million), 2017-2027

 

Table: Europe Diabetes Care Devices Size, By Application, By Value (USD Million), 2017-2027

 

Table: Europe Diabetes Care Devices Size, By End User, By Value (USD Million), 2017-2027

 

Table: Europe Diabetes Care Devices Size, By Country, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Diabetes Care Devices Size, By Application, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Diabetes Care Devices Size, By End User, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Diabetes Care Devices Size, By Country, By Value (USD Million), 2017-2027

 

Table: Latin America Diabetes Care Devices Size, By Application, By Value (USD Million), 2017-2027

 

Table: Latin America Diabetes Care Devices Size, By End User, By Value (USD Million), 2017-2027

 

Table: Latin America Diabetes Care Devices Size, By Country, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Diabetes Care Devices Size, By Application, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Diabetes Care Devices Size, By End User, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Diabetes Care Devices Size, By Country, By Value (USD Million), 2017-2027

 

Table: Novo Nordisk A/S Financial Analysis

Table: Novo Nordisk A/S Business Overview

Table: F. Hoffman-La Roche Ltd. Financial Analysis

Table: F. Hoffman-La Roche Ltd. Business Overview

Table: Rossmax International Ltd. Financial Analysis

Table: Rossmax International Ltd. Business Overview

Table: Medtronic PLC Financial Analysis

Table: Medtronic PLC Business Overview

Table: Sinocare, Inc. Financial Analysis

Table: Sinocare, Inc. Business Overview

Table: Ascensia Diabetes Care Holdings AG Financial Analysis

Table: Ascensia Diabetes Care Holdings AG Business Overview

Table: Abbott Financial Analysis

Table: Abbott Business Overview

Table: Rossmax International Ltd. Financial Analysis

Table: Rossmax International Ltd. Business Overview

Table: Arkray, Inc. Financial Analysis

Table: Arkray, Inc. Business Overview

Table: Dexcom, Inc. Financial Analysis

Table: Dexcom, Inc. Business Overview

Table: Bionime Corporation Financial Analysis

Table: Bionime Corporation Financial Analysis

Table: Lifescan Financial Analysis

Table: Lifescan Business Overview

Table: Dr. Morepen Financial Analysis

Table: Dr. Morepen Business Overview

Table: Sanofi Financial Analysis

Table: Sanofi Business Overview

Table: B. Braun Melsungen AG Financial Analysis

Table: B. Braun Melsungen AG Business Overview

Table: Acon Laboratories, Inc. Financial Analysis

Table: Acon Laboratories, Inc. Business Overview

Table: Becton, Dickinson And Company Financial Analysis

Table: Becton, Dickinson And Company Business Overview

Table: Ypsomed Financial Analysis

Table: Ypsomed Business Overview

Table: Terumo Corporation Financial Analysis

Table: Terumo Corporation Business Overview